Pulsar 1

About Sonosine

Sonosine is a private, pre-revenue deep-tech company developing a disruptive medical imaging diagnostic device called the Pulsar 1. Its core technology, Electro Magnetic Acoustics (EMA), integrates radio signals with ultrasound to provide tissue-type information that ultrasound alone cannot, aiming to offer a quicker, safer, and more affordable point-of-care alternative to modalities like MRI. The company targets the global medical imaging market with a product designed to improve the patient journey from point-of-care to diagnosis. Based in London and founded in 2017, Sonosine appears to be in the late-stage development or early commercialization phase for its first product.